Search Results - Fadeeva, Yulia

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study by Qin, Shukui, Chan, Stephen L, Bai, Yuxian, Chen, Zhendong, Jia, Weidong, Jin, Yongdong, Guo, Yabing, Hu, Xiaohua, Meng, Zhiqiang, Liang, Jun, Cheng, Ying, Xiong, Jianping, Ren, Hong, Chen, Yajin, Zeng, Yong, Sultanbaev, Alexander, Pazgan-Simon, Monika, Melisi, Davide, Ponomarenko, Dmitriy, Sinielnikov, Ivan, Yang, Tsai-Sheng, Liang, Xiao, Chen, Chunxia, Wang, Linna, Cheng, Ann-Lii, Vogel, Arndt, Qin, Shukui, Chan, Stephen L, Vogel, Arndt, Gu, Shanzhi, Bai, Yuxian, Ren, Zhenggang, Lin, Xiaoyan, Chen, Zhendong, Hu, Xiaohua, Meng, Zhiqiang, Liang, Jun, Cheng, Ying, Xiong, Jianping, Ren, Hong, Yang, Fang, Zeng, Yong, Sultanbaev, Alexander, Pisetska, Margaryta, Melisi, Davide, Ponomarenko, Dmitriy, Osypchuk, Yurii, Sinielnikov, Ivan, Yang, Tsai-Sheng, Liang, Xiao, Chen, Chunxia, Zhang, Mingxiang, Xu, Li, Li, Da, Ying, Jierer, Zhang, Jingdong, Zhang, Tao, He, Yifu, Jiang, Da, Xing, Baocai, Zhang, Baihong, Wang, Dong, Zhai, Xiaofeng, Liang, Houjie, Cybulska-Stopa, Bozena, Dvorkin, Mikhail, Stroyakovskiy, Daniil, Yen, Chia-Jui, Su, Wei-Wen, Chen, Yen-Hao, Bondarenko, Igor, Fang, Weijia, Gomez-Martin, Carlos, Ryu, Min-Hee, Kim, Han-Sang, Kim, Jee-Hyun, Orlova, Rashida, Fadeeva, Natalia, Makarova, Yulia, Hung, Chao-Hung, Neffa, Maryna, Vynnychenko, Oleksandr, Burgoyne, Adam, Hao, Chunyi, Mohr, Raphael U, Diaz-Beveridge, Roberto, Feliu-Batlle, Jaime, Antonuzzo, Lorenzo, Scartozzi, Mario, Ahn, Mi Sun, Oh, Sung-Yong, Orlov, Sergey, Oksuzoglu, Berna, Rau, Kun-Ming, Krechkovskyi, Oleksandr, Yareshko, Vladimir, Xiong, Henry, Lee, Fa-Chyi, Jiang, Yixing, Verset, Gontran

    Get full text
    Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial by Wenham, Robert M, Pickett, Cheryl A, Park, Sang Yoon, Makarova, Yulia, Krikunova, Ludmila, Bae, Duk-Soo, Zamagni, Claudio, Tognon, Germana, Ortega, Eugenia, Green, Andrew, Burger, Robert, Sanchez, Andres Redondo, Peen, Ulla, Kamelle, Scott, Carney, Michael, Forget, Frédéric, Bentley, James, Sehouli, Jalid, Kato, Hidenori, Shahin, Mark, Bhoola, Snehalkumar, Anderson, Daniel, Pelgrims, Joseph (Gino), Hansen, Vincent, Van den Bulck, Heidi, Yokota, Harushige, Friedman, Richard, Covens, Allan, Hilpert, Felix, Savarese, Antonella, Pignata, Sandro, Teneriello, Michael, Lentz, Samuel, Mannel, Robert, Lim, Peter, Zorr, Andreas, Karck, Ulrich, Aoki, Daisuke, Hirashima, Yasuyuki, Boere, Ingrid, Braly, Patricia, Schilder, Jeanne, Secord, Angeles, Rojas-Espaillat, Luis, Schauer, Christian, Joosens, Eric, Burges, Alexander, Park-Simon, Tjoung-Won, Alabiso, Oscar, Sawasaki, Takashi, Ibañez, Ana Herrero, Spillman, Monique, Moore, David, Verhoeven, Didier, Schnappauf, Benjamin, Schmalzrie, Hannah, Kalofonos, Haralambos, Diaz, Cristina Caballero, Polo, Susana Hernando, Garrison, Mitchell, Basil, Jack, Cosin, Jonathan, Wade III, James, Buekers, Thomas, DAndre, Stacy, Bakkum-Gamez, Jamie, Van Le, Linda, Puls, Larry, Michelson, Elizabeth Dickson, Kerger, Joseph, Heubner, Martin, Lordick, Florian, Villanueva, William Orlando Brito, Kessels, Lonneke, Fabregat, Miguel Beltran, Kumar, Pallavi, Karimi, Misagh, Edraki, Babak, Morris, Robert, Method, Michael, Drake, Janet, Wadsworth, Troy, Hurteau, Jean, Malad, Salman, Robinson-Bennett, Bernice, Davidson, Susan, Gaur, Rakesh, Krasner, Carolyn, Ueland, Frederick, Talmage, Lance, Sutton, Gregory, Osborne, Janet, Williams, James, Fleming, Nicole, Herzog, Thomas, Leitao, Mario, Mendez, Luis, Patel, Dhimant, Spitzer, Gary, Miller, Brigitte

    Published in The lancet oncology
    Get full text
    Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20